Clinical Trials
UK government, Manufacturing, Investment, Clinical trials
The UK government will improve manufacturing and commercialisation as it seeks to maximise the value of the life sciences sector growth for the country's economy.
In a new Life Sciences sector growth plan, the government established a six-point action plan...
Clinical Trials
AI in Alzheimer Drug Development to Enhances Clinical Trials
Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical treatment. The study shows that AI can help design future clinical trials to be...
Clinical Trials
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly HIV Prevention Pill
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating the safety and efficacy of MK-8527, an investigational once-monthly, oral nucleoside reverse transcriptase translocation...
Drug Research
China Unveils Innovative Drugs Policy to Boost Development
The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality Development of Innovative Drugs". The policy, which was formally unveiled to the...
Drug Research
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D...
BioPharma
Biopharma Production with AI: A New Era in Manufacturing
A New Era of Biopharma Production with AI
The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to revolutionise production processes. Manufacturers are currently facing the most significant challenge in history: the...
BioPharma
AI Drug Discovery Transforming APAC Biopharma Innovation
The Asia-Pacific (APAC) biopharmaceutical space is being revolutionized by the tremendous progress made in artificial intelligence (AI). The use of AI technologies to drive drug discovery is not just a fad but a paradigm shift transforming the way new...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.